Check-Cap (MBAI) Long-Term Investments (2012 - 2025)

Check-Cap (MBAI) posted Long-Term Investments of $1.3 million for Q4 2025, down 70.54% sequentially from $4.3 million in Q2 2025.

Check-Cap (MBAI) Long-Term Investments (2012 - 2025) Analysis & Trends

Check-Cap has reported Long-Term Investments for 5 years, with the latest figure at $1.3 million in Q4 2025.

Quarterly Long-Term Investments changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
Long-Term Investments retreated to $1.3 million in Q4 2025 per MBAI's latest filing, from $4.3 million in the prior quarter.
Over five years, Long-Term Investments peaked at $4.3 million in Q2 2025 and troughed at $1.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Thermo Fisher Scientific	213.44 Bn	209.37 Bn	8.34 Bn	-
2	Danaher	139.95 Bn	135.60 Bn	3.61 Bn	-
3	Idexx Laboratories	46.16 Bn	45.96 Bn	779.09 Mn	-
4	Agilent Technologies	39.67 Bn	37.87 Bn	990.00 Mn	136.00 Mn
5	Iqvia Holdings	39.29 Bn	37.21 Bn	1.44 Bn	390.00 Mn
6	Natera	38.61 Bn	37.51 Bn	696.04 Mn	-
7	Illumina	29.99 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.51 Bn	650.22 Mn	-
9	Quest Diagnostics	26.17 Bn	25.55 Bn	1.03 Bn	137.00 Mn
10	Check-Cap	8.04 Mn	6.42 Mn	-	1.26 Mn

Download Data